Cheryl D. Helgason
675 West 10th Avenue, V5Z 1L3
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
DNA methylation at enhancer regions: Novel avenues for epigenetic biomarker development.
Journal: Frontiers in bioscience (Landmark edition)
Published: December 29, 2015
Elevated expression of the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive biomarker in human cancers.
Journal: International journal of cancer
Published: December 09, 2015
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer.
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer.
Journal: Clinical epigenetics
Published: November 27, 2015
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia.
Journal: Epigenomics
Published: September 08, 2015
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression.
Journal: Molecular oncology
Published: August 28, 2015
The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.
Journal: Molecular cancer
Published: November 18, 2014
Polycomb-mediated silencing in neuroendocrine prostate cancer.
Journal: Clinical epigenetics
Published: November 12, 2014
Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role.
Journal: British journal of cancer
Published: March 18, 2014
The non-coding transcriptome as a dynamic regulator of cancer metastasis.
Journal: Cancer metastasis reviews
Published: December 19, 2013
Histone modifications, stem cells and prostate cancer.
Journal: Current pharmaceutical design
Published: April 20, 2013
Last Updated: 09/26/2026